Kiribati vs Sweden: The number of people with susceptibility test result for rifampicin
Kiribati
96.72
in 2021
Sweden
96.65
in 2021
Kiribati rank
41st
Sweden rank
42nd
The number of people with susceptibility test result for rifampicin over time
- Kiribati
- Sweden
How they compare
Kiribati currently reports 96.72 against 96.65 in Sweden, a difference of 0.07.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Sweden ahead.
Kiribati ranks 41st and Sweden ranks 42nd of 146 countries.
Sweden has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kiribati | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.85 | 97.51 | 30.66 | Sweden |
| 2020s | 93.91 | 96.61 | 2.7 | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Kiribati or Sweden?
- Kiribati, at 96.72 against 96.65 in Sweden as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Kiribati and Sweden?
- 0.07, with Kiribati ahead.
- How many years of comparable data are there for Kiribati and Sweden?
- 5 years are reported by both, from 2017 to 2021.
- How do Kiribati and Sweden rank globally for the number of people with susceptibility test result for rifampicin?
- Kiribati ranks 41st and Sweden ranks 42nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.